Work

Type 1 diabetes: recent developments

Year: 2004
Type: review
Abstract: Type 1 diabetes is one of the most common chronic childhood illnesses, affecting 18 to 20 per 100 000 children a year in the United Kingdom. 1 The American Diabetes Association committee recommends the term type 1A diabetes for immune mediated diabetes with its destruction of the islet cells of the pancreas.2 Nonimmune mediated diabetes with severe insulin deficiency is termed type 1B.In this review, we will use the term type 1 diabetes to refer to immune mediated type 1A diabetes.At present, the development of type 1 diabetes is a life sentence to a difficult therapeutic regimen that is only partially effective in preventing acute and chronic complications.We will concentrate here on recent advances in our understanding of the epidemiology, pathogenesis, prediction, and prevention of type 1 diabetes and new treatments for the disease. Sources and selection criteriaThis review is based on information obtained from a recent Medline search with type 1 diabetes, pathogenesis, prediction, prevention, and treatment as key words.We also consulted summaries of the literature on type 1 diabetes (available with teaching slides at www.barbaradaviscenter.org).
Source: BMJ
Language: English
Subfield: Genetics
Open Access status: bronze
OpenAlex ID: W2095528440
FWCI: 2.599
Cites: 35
Cited by: 363
Related to: 10